Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
You can change this under Settings & Account at any time.
antiangiogenic drugs as a targeted drug therapy
Transcript of antiangiogenic drugs as a targeted drug therapy
Angiogenesis and cancer
side effects and resistance
what is Angiogenesis?
A new blood vessel is coming to be created
Angiogenesis and Cancer
DID we make it ?
Yes we did.
Wounds that don't heal
so,we can target cancer cell from this point
Antiangiogenic Drugs as a Targeted Drug Therapy
to be more specific: :
Creating new blood vessel is done by two mechanisms:
de novo synthesis of blood vessels
creation of new vessels from already existing vessels.
when do we need it?
female reproductive system
(wound healing and tumor growth)
VEGF + PDGF
a tumor needs an independent blood supply, which is acquired by the expression of growth factors that recruit new vasculature from existing blood vessels
tumor growth and metastasis is angiogenesis-dependent
excessive production of angiogenic growth factors
excessive expression of their receptors
Tyrosine kinase receptor
The goal of their use:
a) therapeutic goal
synergistic effect with other drugs
b) protective goal
decrease systemic side effects
improve patients' quality of life
classification of antiangiogenic drugs
1-vascular endothelial growth factor receptor (VEGFR) inhibitors:
a) Tyrosine kinase and multi-kinase inhibitors:
b) Monoclonal antibodies
2-inhibitors of endothelial cell proliferation.
monoclonal antibody against VEGF
FDA Approved for:
1st angiogenesis inhibitor that was
slow tumor growth
extend the lives of patients.
Recurrent glioblastoma - alone
NSCLC - with carboplatin and paclitaxel
Metastatic Kidney cancer - with interferon alfa
Advanced Cervical cancer - with paclitaxel and cisplatin
small molecular inhibitor of several tyrosine protein kinases including:
Raf, MEK, ERK
advanced kidney cancer
advanced liver cancer
I-resistant thyroid cancer
and most important:
TKIs against the ABL family:
and much more
Did our bodies accept these drugs?
Take care if you are:
breast feeding mother
How did cancer deal with these drugs?
there is a must to develop a new class of drugs that inhibit the mutant VEGF and its receptor, and not the normal wild types, and to target the escaping mechanisms of the cancer.